8HF-57498-51630
5 vaccinations
10 coded responses
64 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 560 / MN
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Immediate post-injection reaction, Paraesthesia — Feeling: Good · Site: Pain · Fever · ChillsFree text: Arm tingling first 12 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-11
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workFree text: Axillary lymph nodes swollenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: Axillary lymph node swelling injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-04-12
- 2021-07-12
-
2021-10-07
Dose 3 — Pfizer-BioNTech
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Pain in extremity — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Pain in injection arm/mild axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2022-01-06
- 2022-04-07
-
2022-05-17
Dose 4 — Pfizer-BioNTech
- 2022-05-17
-
2022-05-18
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Mild left axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2022-05-19
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Fatigue or tirednessFree text: Still mild axillary lymphadenopathy injection armMedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Fatigue or tirednessFree text: Still mild axillary lymphadenopathy injection armMedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Still mild axillary lymphadenopathy in the injection arm.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-22
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: Still with mild axillary lymphadenopathy injection arm.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-23
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Still with mild axillary lymphadenopathy on injection arm.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-24
- 2022-05-31
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-06-28
- 2022-08-16
-
2022-10-21
Dose 5 — Pfizer-BioNTech
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-02
- 2023-01-21
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-10-07 | Pfizer-BioNTech | No |
| 4 | 2022-05-17 | Pfizer-BioNTech | No |
| 5 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Arm tingling first 12 hours
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymph nodes swollen
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymph node swelling injection arm
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Pain in injection arm/mild axillary lymphadenopathy
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Mild left axillary lymphadenopathy
Systemic reaction (other): Still mild axillary lymphadenopathy injection arm
Systemic reaction (other): Still mild axillary lymphadenopathy injection arm
Systemic reaction (other): Still mild axillary lymphadenopathy in the injection arm.
Systemic reaction (other): Still with mild axillary lymphadenopathy injection arm.
Systemic reaction (other): Still with mild axillary lymphadenopathy on injection arm.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release